The objective of this research is to use a combination of EPR, ENDOR, NMR, X-ray crystallographic, synthetic and computational methods to investigate the structure, function, and inhibition of isoprenoid biosynthesis enzymes of interest as drug targets for treating, primarily, tropical diseases.
In Aim 1, we will investigate GcpE, an enzyme involved in isoprenoid biosynthesis in malaria parasites. We hypothesize that its mechanism of action involves unusual metallacycles and that similar metallacycles form with novel alkyne inhibitors. GcpE is an excellent target for the development of novel anti-infectives since it is essential for pathogen survival, is not found in humans, and we have now identified novel inhibitors.
In Aim 2 we will carry out a similar series of investigations of the following enzyme (from P. falciparum) in the pathway, LytB, and we hypothesize that because of similarities in their mechanism of action, LytB inhibitors will also inhibit GcpE leading, in cells, to synergistic activity.
The third Aim i s to develop novel anti-malarials that function by blocking carotenoid and quinone biosynthesis. Carotenoids act to remove reactive oxygen species (ROS, from hemoglobin catabolism) and we hypothesize that carotenoid (and quinone) biosynthesis inhibitors will synergize with current anti-malarials (that enhance ROS formation), reducing drug resistance.
The final Aim i nvolves investigation of three other high-value targets: in trypanosomatid parasites, farnesyl diphosphate synthase and hexokinase, in bacteria, undecaprenyl diphosphate synthase. All are essential for survival and sub-micromolar leads have already been identified by us. If successful, the work will provide many new insights into enzyme mechanisms, as well as new drug leads for many global infectious diseases.

Public Health Relevance

This project is aimed at developing new leads for treating infectious diseases, primarily malaria. Focus will be on developing inhibitors for three unique targets in malaria parasites, and on the use of novel drugs against sleeping sickness.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM065307-11
Application #
8324616
Study Section
Macromolecular Structure and Function E Study Section (MSFE)
Program Officer
Anderson, Vernon
Project Start
2002-06-01
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
11
Fiscal Year
2012
Total Cost
$347,455
Indirect Cost
$114,805
Name
University of Illinois Urbana-Champaign
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Champaign
State
IL
Country
United States
Zip Code
61820
Malwal, Satish R; O'Dowd, Bing; Feng, Xinxin et al. (2018) Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways. J Am Chem Soc 140:7568-7578
Malwal, Satish R; Gao, Jian; Hu, Xiangying et al. (2018) Catalytic Role of Conserved Asparagine, Glutamine, Serine, and Tyrosine Residues in Isoprenoid Biosynthesis Enzymes. ACS Catal 8:4299-4312
Kang, Lu; Gao, Xiao-Hui; Liu, Hao-Ran et al. (2018) Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors. Mol Divers :
Elsebaei, Mohamed M; Mohammad, Haroon; Abouf, Mohamed et al. (2018) Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA). Eur J Med Chem 148:195-209
Rao, Guodong; Bansal, Sandhya; Law, Wen Xuan et al. (2017) Pulsed Electron Paramagnetic Resonance Insights into the Ligand Environment of Copper in Drosophila Lysyl Oxidase. Biochemistry 56:3770-3779
O'Dowd, Bing; Williams, Sarah; Wang, Hongxin et al. (2017) Spectroscopic and Computational Investigations of Ligand Binding to IspH: Discovery of Non-diphosphate Inhibitors. Chembiochem 18:914-920
Boulmier, Amandine; Feng, Xinxin; Oms, Olivier et al. (2017) Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results. Inorg Chem 56:7558-7565
Mohammad, Haroon; Younis, Waleed; Chen, Lu et al. (2017) Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci. J Med Chem 60:2425-2438
Schwalen, Christopher J; Feng, Xinxin; Liu, Weidong et al. (2017) Head-to-Head Prenyl Synthases in Pathogenic Bacteria. Chembiochem 18:985-991
Desai, Janish; Wang Dr, Yang; Wang Dr, Ke et al. (2016) Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth. ChemMedChem 11:2205-2215

Showing the most recent 10 out of 97 publications